- Home
- MAA vs MIST Comparison
MAA vs MIST Comparison
Compare MAA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAA
- MIST
- Stock Information
- Founded
- MAA 1977
- MIST 2003
- Country
- MAA United States
- MIST Canada
- Employees
- MAA N/A
- MIST N/A
- Industry
- MAA Real Estate Investment Trusts
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- MAA Real Estate
- MIST Health Care
- Exchange
- MAA Nasdaq
- MIST Nasdaq
- Market Cap
- MAA 19.0B
- MIST 53.9M
- IPO Year
- MAA 1994
- MIST N/A
- Fundamental
- Price
- MAA $162.99
- MIST $1.11
- Analyst Decision
- MAA Buy
- MIST Strong Buy
- Analyst Count
- MAA 20
- MIST 2
- Target Price
- MAA $175.60
- MIST $9.50
- AVG Volume (30 Days)
- MAA 889.7K
- MIST 1.6M
- Earning Date
- MAA 04-30-2025
- MIST 05-20-2025
- Dividend Yield
- MAA 3.71%
- MIST N/A
- EPS Growth
- MAA 0.75
- MIST N/A
- EPS
- MAA 4.81
- MIST N/A
- Revenue
- MAA $2,196,688,000.00
- MIST N/A
- Revenue This Year
- MAA $2.65
- MIST N/A
- Revenue Next Year
- MAA $3.82
- MIST N/A
- P/E Ratio
- MAA $33.97
- MIST N/A
- Revenue Growth
- MAA 1.55
- MIST N/A
- 52 Week Low
- MAA $126.77
- MIST $0.63
- 52 Week High
- MAA $173.38
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- MAA 53.51
- MIST 43.96
- Support Level
- MAA $163.48
- MIST $1.28
- Resistance Level
- MAA $166.04
- MIST $1.32
- Average True Range (ATR)
- MAA 3.34
- MIST 0.12
- MACD
- MAA 0.57
- MIST 0.02
- Stochastic Oscillator
- MAA 56.42
- MIST 27.39
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).